Schedule 13D ownership disclosure

CHEMOMAB THERAPEUTICS LTD

Security class unavailable · CUSIP: 16385C104

Event date: 2024-03-11

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
16.0000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000947871-24-000279
Form type
SC 13D/A
Filer
Chemomab Therapeutics Ltd.
CIK
CIK 1534248
Filed
Mar 11, 2024
Reporting period
Mar 11, 2024
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub